BANK VONTOBEL/CALL/PFIZER INC/37/0.1/17.01.25 Share Price

Warrant

DE000VM9BY30

Real-time Boerse Frankfurt Warrants 09:30:45 04/07/2024 BST
0.019 EUR +11.76% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/37/0.1/17.01.25
Current month-10.53%
1 month-60.47%
Date Price Change
04/07/24 0.019 +11.76%
03/07/24 0.017 -15.00%
02/07/24 0.02 -13.04%
01/07/24 0.023 +21.05%
28/06/24 0.019 -5.00%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 09:30 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9BY3
ISINDE000VM9BY30
Date issued 30/01/2024
Strike 37 $
Maturity 17/01/2025 (198 Days)
Parity 10 : 1
Emission price 0.05
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.068
Lowest since issue 0.014
Spread 0.01
Spread %33.33%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus